277 related articles for article (PubMed ID: 31391869)
1. Neoadjuvant therapy of locally/regionally advanced melanoma.
Khunger A; Buchwald ZS; Lowe M; Khan MK; Delman KA; Tarhini AA
Ther Adv Med Oncol; 2019; 11():1758835919866959. PubMed ID: 31391869
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant therapy for melanoma: a promising therapeutic approach and an ideal platform in drug development.
Tarhini AA
Am Soc Clin Oncol Educ Book; 2015; ():e535-42. PubMed ID: 25993220
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant immunotherapy of locoregionally advanced solid tumors.
Tarhini AA; Eads JR; Moore KN; Tatard-Leitman V; Wright J; Forde PM; Ferris RL
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35973745
[TBL] [Abstract][Full Text] [Related]
4. Systemic treatments for metastatic cutaneous melanoma.
Pasquali S; Hadjinicolaou AV; Chiarion Sileni V; Rossi CR; Mocellin S
Cochrane Database Syst Rev; 2018 Feb; 2(2):CD011123. PubMed ID: 29405038
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant therapy for high-risk bulky regional melanoma.
Tarhini AA; Pahuja S; Kirkwood JM
J Surg Oncol; 2011 Sep; 104(4):386-90. PubMed ID: 21858833
[TBL] [Abstract][Full Text] [Related]
6. The Role of Neoadjuvant Therapy in Melanoma.
Kelly ZR; Gorantla VC; Davar D
Curr Oncol Rep; 2020 Jun; 22(8):80. PubMed ID: 32601947
[TBL] [Abstract][Full Text] [Related]
7. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant Immunotherapy for Locally Advanced Melanoma.
Pelster MS; Amaria RN
Curr Treat Options Oncol; 2020 Feb; 21(2):10. PubMed ID: 32025932
[TBL] [Abstract][Full Text] [Related]
9. Challenges and Opportunities of Neoadjuvant Treatment in Locally Advanced Melanoma.
McKean MA; Amaria RN
Am J Clin Dermatol; 2018 Oct; 19(5):639-646. PubMed ID: 30039289
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant ipilimumab (3 mg/kg or 10 mg/kg) and high dose IFN-α2b in locally/regionally advanced melanoma: safety, efficacy and impact on T-cell repertoire.
Tarhini A; Lin Y; Lin H; Rahman Z; Vallabhaneni P; Mendiratta P; Pingpank JF; Holtzman MP; Yusko EC; Rytlewski JA; Rao UNM; Ferris RL; Kirkwood JM
J Immunother Cancer; 2018 Oct; 6(1):112. PubMed ID: 30352626
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary treatment strategies in high-risk resectable melanoma: Role of adjuvant and neoadjuvant therapy.
McKean MA; Amaria RN
Cancer Treat Rev; 2018 Nov; 70():144-153. PubMed ID: 30195813
[TBL] [Abstract][Full Text] [Related]
12. How to use neoadjuvant medical treatment to maximize surgery in melanoma.
Amaral T; Tampouri I; Garbe C
Expert Rev Anticancer Ther; 2018 Feb; 18(2):121-130. PubMed ID: 29271674
[TBL] [Abstract][Full Text] [Related]
13. The emergence of neoadjuvant therapy in advanced melanoma.
Sun J; Kirichenko DA; Zager JS; Eroglu Z
Melanoma Manag; 2019 Oct; 6(3):MMT27. PubMed ID: 31807278
[TBL] [Abstract][Full Text] [Related]
14. Treatment Approaches for Melanomas That Relapse After Adjuvant or Neoadjuvant Therapy.
Ng G; Xu W; Atkinson V
Curr Oncol Rep; 2022 Oct; 24(10):1273-1280. PubMed ID: 35639333
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant Therapy in Melanoma: Where Are We Now?
Saad M; Tarhini AA
Curr Oncol Rep; 2023 Apr; 25(4):325-339. PubMed ID: 36781621
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now.
Long GV; Menzies AM; Scolyer RA
J Clin Oncol; 2023 Jun; 41(17):3236-3248. PubMed ID: 37104746
[TBL] [Abstract][Full Text] [Related]
17. Emerging role of taxanes in adjuvant and neoadjuvant therapy for breast cancer: the potential and the questions.
Goble S; Bear HD
Surg Clin North Am; 2003 Aug; 83(4):943-71. PubMed ID: 12875604
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma.
Ferraresi V; Vari S
Hum Vaccin Immunother; 2022 May; 18(3):1971015. PubMed ID: 34882516
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant treatment for melanoma: current challenges and future perspectives.
Najjar YG; Kirkwood JM
Melanoma Manag; 2016 Jun; 3(2):149-159. PubMed ID: 30190883
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant and Neoadjuvant Therapies in Cutaneous Melanoma.
Ponto J; Bell RB
Oral Maxillofac Surg Clin North Am; 2022 May; 34(2):315-324. PubMed ID: 35491081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
